Cargando…

Co-Developing Patient-Centered Information: A Focus Group Study of Asthma Patients’ Preferences and Attitudes towards New Medical Treatment Guidelines

Studies have suggested patient involvement as an important factor when seeking to improve patient-centered information. The objective of this study was to explore asthma patients’ preferences regarding information when co-developing patient-centered information and how they evaluate the material as...

Descripción completa

Detalles Bibliográficos
Autores principales: Holst, Sara Sommer, Vermehren, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059206/
https://www.ncbi.nlm.nih.gov/pubmed/36986555
http://dx.doi.org/10.3390/ph16030456
_version_ 1785016818332598272
author Holst, Sara Sommer
Vermehren, Charlotte
author_facet Holst, Sara Sommer
Vermehren, Charlotte
author_sort Holst, Sara Sommer
collection PubMed
description Studies have suggested patient involvement as an important factor when seeking to improve patient-centered information. The objective of this study was to explore asthma patients’ preferences regarding information when co-developing patient-centered information and how they evaluate the material as a supportive initiative when they are deciding whether to switch to the new MART approach. The study was performed as a case study involving qualitative semi-structured focus group interviews inspired by the theoretical framework for supporting patient involvement in research. Two focus group interviews were held, with a total of nine interviewees. Three main interview themes were found: the identification of important topics about the new MART approach, feedback on the design and the preferred implementation of written patient-centered information. The asthma patients preferred written patient-centered material to be short and to be presented briefly at the local community pharmacy, and then discussed more thoroughly with their general practitioner (GP) at a consultation. In conclusion, this study identified asthma patients’ preferences when co-developing written patient-centered information and how the patients favored the material to be implemented as a support to them in their decision on whether to change asthma treatment.
format Online
Article
Text
id pubmed-10059206
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100592062023-03-30 Co-Developing Patient-Centered Information: A Focus Group Study of Asthma Patients’ Preferences and Attitudes towards New Medical Treatment Guidelines Holst, Sara Sommer Vermehren, Charlotte Pharmaceuticals (Basel) Article Studies have suggested patient involvement as an important factor when seeking to improve patient-centered information. The objective of this study was to explore asthma patients’ preferences regarding information when co-developing patient-centered information and how they evaluate the material as a supportive initiative when they are deciding whether to switch to the new MART approach. The study was performed as a case study involving qualitative semi-structured focus group interviews inspired by the theoretical framework for supporting patient involvement in research. Two focus group interviews were held, with a total of nine interviewees. Three main interview themes were found: the identification of important topics about the new MART approach, feedback on the design and the preferred implementation of written patient-centered information. The asthma patients preferred written patient-centered material to be short and to be presented briefly at the local community pharmacy, and then discussed more thoroughly with their general practitioner (GP) at a consultation. In conclusion, this study identified asthma patients’ preferences when co-developing written patient-centered information and how the patients favored the material to be implemented as a support to them in their decision on whether to change asthma treatment. MDPI 2023-03-17 /pmc/articles/PMC10059206/ /pubmed/36986555 http://dx.doi.org/10.3390/ph16030456 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Holst, Sara Sommer
Vermehren, Charlotte
Co-Developing Patient-Centered Information: A Focus Group Study of Asthma Patients’ Preferences and Attitudes towards New Medical Treatment Guidelines
title Co-Developing Patient-Centered Information: A Focus Group Study of Asthma Patients’ Preferences and Attitudes towards New Medical Treatment Guidelines
title_full Co-Developing Patient-Centered Information: A Focus Group Study of Asthma Patients’ Preferences and Attitudes towards New Medical Treatment Guidelines
title_fullStr Co-Developing Patient-Centered Information: A Focus Group Study of Asthma Patients’ Preferences and Attitudes towards New Medical Treatment Guidelines
title_full_unstemmed Co-Developing Patient-Centered Information: A Focus Group Study of Asthma Patients’ Preferences and Attitudes towards New Medical Treatment Guidelines
title_short Co-Developing Patient-Centered Information: A Focus Group Study of Asthma Patients’ Preferences and Attitudes towards New Medical Treatment Guidelines
title_sort co-developing patient-centered information: a focus group study of asthma patients’ preferences and attitudes towards new medical treatment guidelines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059206/
https://www.ncbi.nlm.nih.gov/pubmed/36986555
http://dx.doi.org/10.3390/ph16030456
work_keys_str_mv AT holstsarasommer codevelopingpatientcenteredinformationafocusgroupstudyofasthmapatientspreferencesandattitudestowardsnewmedicaltreatmentguidelines
AT vermehrencharlotte codevelopingpatientcenteredinformationafocusgroupstudyofasthmapatientspreferencesandattitudestowardsnewmedicaltreatmentguidelines